These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19733888)
1. Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Conway MJ; Alam S; Christensen ND; Meyers C Virology; 2009 Oct; 393(2):295-303. PubMed ID: 19733888 [TBL] [Abstract][Full Text] [Related]
2. Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. Campos SK; Ozbun MA PLoS One; 2009; 4(2):e4463. PubMed ID: 19214230 [TBL] [Abstract][Full Text] [Related]
3. Role of L2 cysteines in papillomavirus infection and neutralization. Gambhira R; Jagu S; Karanam B; Day PM; Roden R Virol J; 2009 Oct; 6():176. PubMed ID: 19860897 [TBL] [Abstract][Full Text] [Related]
4. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins. Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry. Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736 [TBL] [Abstract][Full Text] [Related]
7. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365 [TBL] [Abstract][Full Text] [Related]
8. Arrangement of L2 within the papillomavirus capsid. Buck CB; Cheng N; Thompson CD; Lowy DR; Steven AC; Schiller JT; Trus BL J Virol; 2008 Jun; 82(11):5190-7. PubMed ID: 18367526 [TBL] [Abstract][Full Text] [Related]
9. Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. Conway MJ; Alam S; Ryndock EJ; Cruz L; Christensen ND; Roden RB; Meyers C J Virol; 2009 Oct; 83(20):10515-26. PubMed ID: 19656879 [TBL] [Abstract][Full Text] [Related]
10. Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes. Conway MJ; Cruz L; Alam S; Christensen ND; Meyers C PLoS One; 2011 Feb; 6(2):e16405. PubMed ID: 21346798 [TBL] [Abstract][Full Text] [Related]
11. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis. Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294 [TBL] [Abstract][Full Text] [Related]
12. Study of infectious virus production from HPV18/16 capsid chimeras. Chen HS; Bromberg-White J; Conway MJ; Alam S; Meyers C Virology; 2010 Sep; 405(2):289-99. PubMed ID: 20598725 [TBL] [Abstract][Full Text] [Related]
13. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes. Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963 [TBL] [Abstract][Full Text] [Related]
15. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens. Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304 [No Abstract] [Full Text] [Related]
16. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16. Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785 [TBL] [Abstract][Full Text] [Related]
17. Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. Conway MJ; Cruz L; Alam S; Christensen ND; Meyers C PLoS One; 2011; 6(7):e22427. PubMed ID: 21811610 [TBL] [Abstract][Full Text] [Related]
18. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. Yang R; Day PM; Yutzy WH; Lin KY; Hung CF; Roden RB J Virol; 2003 Mar; 77(6):3531-41. PubMed ID: 12610128 [TBL] [Abstract][Full Text] [Related]
19. Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Pastrana DV; Gambhira R; Buck CB; Pang YY; Thompson CD; Culp TD; Christensen ND; Lowy DR; Schiller JT; Roden RB Virology; 2005 Jul; 337(2):365-72. PubMed ID: 15885736 [TBL] [Abstract][Full Text] [Related]
20. The critical residues of helix 5 for in vitro pentamer formation and stability of the papillomavirus capsid protein, L1. Jin S; Pan D; Zha X; Yu X; Wu Y; Liu Y; Yin F; Chen XS Mol Biosyst; 2014 Apr; 10(4):724-7. PubMed ID: 24469550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]